What's New at the WY Capitol

As cancer care professionals who experience the challenges of providing quality cancer care first-hand, WSOS members are well positioned to educate decision-makers on how coverage and reimbursement issues affect community oncology. State and federal legislation can have a significant impact on the financial viability of local cancer programs, which is why it's so important that our members make their voices heard. 

We want to hear from you! If there is a specific piece of legislation you want to know more about, an important resource we're missing, or if you want to get more involved, please contact us!

Implementing the New CMS Reimbursement Billing Codes for Patient Navigation Services

As of January 1, 2024, the Centers for Medicare and Medicaid Services introduced new codes so that Medicare could reimburse for patient navigation services. To address challenges of implementation, the Association of Cancer Care Centers, in partnership with TACOS and 11 other state societies from CO, IN, IA, NV, NM, NY, NC, SC, WA, WI, and WY, has a 4-part webinar series, Implementing the New CMS Reimbursement Billing Codes for Patient Navigation Services, hosted by Teri Bedard of Revenue Cycle Coding Strategies.

Early cancer detection gives more Wyomingites a fighting chance

April 15, 2023

WSOS President Amy D. Smith is featured in the Laramie Boomerang, discussing her gratitude for support from Senators Lummis and Barrasso who have championed the Multi-Cancer Early Detection Screening Coverage Act. This goal of this legislation is to bridge the geographic care-gap that many Wyomingites have in accessing cancer early detection tools.

Read the Full Article

WSOS Joins 400+ Organizations in Support of MCED Legislation

May 5, 2022

The Wyoming State Oncology Society (WSOS) joined more than 400 organization from all 50 states to urge Congress to pass the Medicare Multi-Cancer Early Detection (MCED) Screening Coverage Act (H.R.1946/S.1873) this year. This legislation would create a pathway for MCED tests to be covered by the Medicare program following approval by the Food and Drug Administration (FDA).

Read the Letter